New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology Reports"
DOI: 10.1007/s11912-022-01218-y
Abstract: Even though checkpoint inhibitors have become a recent milestone for the treatment of many different tumor types, eventually, most part of patients will develop resistance mechanisms and their disease will progress. New generations of checkpoint… read more here.
Keywords: tim; new checkpoint; inhibitors road; road targeting ... See more keywords